MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...

The injection of stem cells into the brains of patients living with multiple sclerosis (MS) could help protect the brain from further damage, researchers have found in the early stage of a new ...

There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS ...

The centre in Canterbury wants to bring specialist therapy closer to home for more people in Kent.

Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...

The therapeutic landscape for multiple sclerosis (MS) is evolving beyond modulating the peripheral immune response. New strategies are now focussed on reducing inflammation and promoting the ...

A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...